Radical sequestration by protein-bound 3,4-dihydroxyphenylalanine

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 5, 2010, Pages 755-761

  Nelson, Michelle ^a   Foxwell, A Ruth ^a   Tyrer, Peter ^b   Dean, Roger T ^a  

^a UNIVERSITY OF CANBERRA   (Australia)

^b CANBERRA HOSPITAL   (Australia)

Author keywords

Antioxidant activity; Oxidative stress; Protein oxidation; Protein bound DOPA; Radical scavenging

Indexed keywords

DOPA; LACTATE DEHYDROGENASE; LUMINOL; PEROXY RADICAL; TYROSINE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CELL VIABILITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; OXIDATION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN TRANSPORT;

AMIDINES; ANIMALS; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICAL SCAVENGERS; HUMANS; LEVODOPA; LUMINESCENT AGENTS; MICE; MONOCYTES; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN TRANSPORT; PROTEINS; TYROSINE;

EID: 77649184505     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.01.015     Document Type: Article

References (30)

1. Alanko J., Riutta A., Mucha I., Vapaatalo H., and Metsa-Ketela T. Modulation of arachidonic acid metabolism by phenols: relation to positions of hydroxyl groups and peroxyl radical scavenging properties. Free Radical Biology and Medicine 14 (1993) 19-25
2. Alanko J., Riutta A., Holm P., Mucha I., Vapaatalo H., and Metsa-Ketela T. Modulation of arachidonic acid metabolism by phenols: relation to their structure and antioxidant/prooxidant properties. Free Radical Biology and Medicine 26 (1999) 193-201
3. Blandini F., Mangiagalli A., Cosentino M., Marino F., Samuele A., Rasini E., et al. Peripheral markers of apoptosis in Parkinson's disease: the effect of dopaminergic drugs. Annals of the New York Academy of Sciences 1010 (2003) 675-680
4. Blandini F., Cosentino M., Mangiagalli A., Marino F., Samuele A., Rasini E., et al. Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson's disease. The effect of dopaminergic treatment. Journal of Neural Transmission 111 (2004) 1017-1030
5. Cadenas E., Simic M.G., and Sies H. Antioxidant activity of 5-hydroxytryptophan, 5-hydroxyindole, and DOPA against microsomal lipid peroxidation and its dependence on vitamin E. Free Radical Research Communications 6 (1989) 11-17
6. Exner M., Hermann M., Hofbauer R., Kapiotis S., and Gmeiner B.M. Free and peptide-bound DOPA can inhibit initiation of low density lipoprotein oxidation. Free Radical Research 37 (2003) 1147-1156
7. Ferrario J.E., Taravini I.R., Mourlevat S., Stefano A., Delfino M.A., Raisman-Vozari R., et al. Differential gene expression induced by chronic levodopa treatment in the striatum of rats with lesions of the nigrostriatal system. Journal of Neurochemistry 90 (2004) 1348-1358
8. Fu S., Davies M.J., Stocker R., and Dean R.T. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochemical Journal 333 (1998) 519-525
9. Fu S., Dean R., Southan M., and Truscott R. The hydroxyl radical in lens nuclear cataractogenesis. Journal of Biological Chemistry 273 (1998) 28603-28609
10. Gieseg S.P., Simpson J.A., Charlton T.S., Duncan M.W., and Dean R.T. Protein-bound 3,4-dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to proteins. Biochemistry 32 (1993) 4780-4786
11. Goldstein J.L., Ho Y.K., Basu S.K., and Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proceedings of the National Academy of Science, United States of America 76 (1979) 333-337
12. Gulcin I. Comparison of in vitro antioxidant and antiradical activities of l-tyrosine and l-DOPA. Amino Acids 32 (2007) 431-438
13. Han S.K., Mytilineou C., and Cohen G. l-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress. Journal of Neurochemistry 66 (1996) 501-510
14. Husain S., and Hadi S.M. Strand scission in DNA induced by l-DOPA in the presence of Cu(II). FEBS Letters 364 (1995) 75-78
15. Lissi E., Salim-Hanna M., Pascual C., and Del Castillo M.D. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radical Biology and Medicine 18 (1995) 153-158
16. Mena M.A., Davila V., and Sulzer D. Neurotrophic effects of l-DOPA in postnatal midbrain dopamine neuron/cortical astrocyte cocultures. Journal of Neurochemistry 69 (1997) 1398-1408
17. Miura T., Muraoka S., and Fujimoto Y. Inactivation of creatine kinase induced by DOPA and dopamine in the presence of ferrylmyoglobin. Chemico-Biological Interactions 123 (1999) 51-61
18. Morin B., Davies M.J., and Dean R.T. The protein oxidation product 3,4-dihydroxyphenylalanine (DOPA) mediates oxidative DNA damage. Biochemical Journal 330 (1998) 1059-1067
19. Mytilineou C., Han S.K., and Cohen G. Toxic and protective effects of l-DOPA on mesencephalic cell cultures. Journal of Neurochemistry 61 (1993) 1470-1478
20. Nelson M., Foxwell A.R., Tyrer P.C., and Dean R.T. Protein-bound 3,4-dihydroxy-phenylalanine (DOPA), a redox active product of protein oxidation, as a trigger for antioxidant defences. International Journal of Biochemistry and Cell Biology 39 (2007) 879-889
21. Niki E. Free radical initiators as source of water- or lipid-soluble peroxyl radicals. Methods in Enzymology 186 (1990) 100-108
22. Rodgers K.J., Wang H.J., Fu S., and Dean R.T. Biosynthetic incorporation of oxidised amino acids into proteins and their cellular proteolysis. Free Radical Biology and Medicine 32 (2002) 766-775
23. Rodgers K.J., Hume P.M., Dunlop R.A., and Dean R.T. Biosynthesis and turnover of DOPA-containing proteins by human cells. Free Radical Biology and Medicine 37 (2004) 1756-1764
24. Schaffner T., Taylor K., Bartucci E.J., Fischer-Dzoga K., Beeson J.H., Glagov S., et al. Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. American Journal of Pathology 100 (1980) 57-80
25. 2-induced oxidative damage to cellular DNA. Life Sciences 71 (2002) 3047-3057
26. Tanaka M., Yoshida T., Okamoto K., and Hirai S. Dopamine and DOPA cause release of iron from ferritin and lipid peroxidation of liposomes. NeuroReport 10 (1995) 1883-1887
27. Upston J.M., Niu X., Brown A.J., Mashima R., Wang H., Senthilmohan R., et al. Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. American Journal of Pathology 160 (2002) 701-710
28. Valastro B., Dekundy A., Krogh M., Lundblad M., James P., Danysz W., et al. Proteomic analysis of striatal proteins in the rat model of l-DOPA-induced dyskinesia. Journal of Neurochemistry 102 (2007) 1395-1409
29. van Muiswinkel F.L., Riemers F.M., Peters G.J., LaFleur M.V., Siegel D., Jongenelen C.A., et al. l-DOPA stimulates expression of the antioxidant enzyme NAD(P)H:quinone oxidoreductase (NQO) in cultured astroglial cells. Free Radical Biology and Medicine 29 (2000) 442-453
30. Woods A.A., Linton S.M., and Davies M.J. Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. Biochemical Journal 370 (2003) 729-735